Pierce Geoghegan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Pierce Geoghegan

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Med (New York, N.Y.)|March 16, 2022

A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19Oliver J McElvaney, Natalie L McEvoy, Fiona Boland, et al.

American Journal of Respiratory and Critical Care Medicine|June 26, 2020

Characterization of the Inflammatory Response to Severe COVID-19 IllnessOliver J McElvaney, Natalie L McEvoy, Oisín F McElvaney, et al.

Critical Care (London, England)|May 4, 2019

Influenza and associated co-infections in critically ill immunosuppressed patientsIgnacio Martin-Loeches, Virginie Lemiale, Pierce Geoghegan, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Med (New York, N.Y.)|March 16, 2022

A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19Oliver J McElvaney, Natalie L McEvoy, Fiona Boland, et al.

American Journal of Respiratory and Critical Care Medicine|June 26, 2020

Characterization of the Inflammatory Response to Severe COVID-19 IllnessOliver J McElvaney, Natalie L McEvoy, Oisín F McElvaney, et al.

Critical Care (London, England)|May 4, 2019

Influenza and associated co-infections in critically ill immunosuppressed patientsIgnacio Martin-Loeches, Virginie Lemiale, Pierce Geoghegan, et al.

Pageof 3